Keyword: Pharmaceuticals

News

Merck Steers Doctors Away from HDL Cholesterol Drug

13.01.2013 - U.S. drugmaker Merck & Co said it is taking steps to suspend availability of its drug Tredaptive after the medicine, used to raise "good" HDL cholesterol, failed to prevent heart...

News

Swiss Health Insurer Makes Claim Against Bayer Over Yasmin Pill

09.01.2013 - Switzerland's biggest health insurer CSS is supporting a young woman in her claim against Bayer, as the fall-out from alleged side effects of the German drugmaker's contraceptive...

News

Amgen Trims 2012 EPS Estimate, Citing R&D Tax Credit Delay

09.01.2013 - Amgen, the world's largest biotechnology company, on Tuesday lowered its outlook for 2012 earnings per share by 10 cents, citing a delay in the impact of a U.S. tax credit for...

News

Shire Adds to Genetic Disorder Drugs with U.S. Deal

08.01.2013 - British drugmaker Shire has agreed to buy Lotus Tissue Repair, a U.S. biotechnology company developing the first treatment for a rare genetic disorder that causes extremely fragile...

News

China to Cut Prices of More than 400 Drugs from February

08.01.2013 - China will cut prices of about 400 drugs for respiratory diseases, fever and pain by up to 20% from February, in a move to make medicines, including some products from Pfizer...

News

AMRI Promotes Richard A. Saffee to Vice President and General Manager of Large Scale Manufacturing

08.01.2013 - AMRI announced today that Richard A. Saffee has been promoted to the newly created role of Vice President and General Manager of Large Scale Manufacturing, effective immediately...

News

Actelion Sticks to Forecast for Return to Growth from 2014

08.01.2013 - Actelion, Europe's biggest biotech company, is sticking to its forecast for core earnings to return to growth from 2014 as cost cuts and a new heart and lung treatment offset...

News

Celgene Issues 2013, Long-term Forecasts

08.01.2013 - Celgene on Monday forecast 2013 profit in line with Wall Street projections, introduced a long-term outlook for 2017, and said results from two late-stage trials of a drug for the...